Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Endocrinology

Your Long-Term Care and Monitoring Plan

At a Glance

Long-term management of Autosomal Dominant Hypocalcemia (ADH) requires keeping blood calcium in the low-normal range to prevent permanent kidney damage. Patients need an endocrinologist and a nephrologist to monitor regular blood work and 24-hour urine tests.

Managing Autosomal Dominant Hypocalcemia (ADH) is a marathon, not a sprint. Because this condition involves a complex interplay between your parathyroid glands and your kidneys, a structured monitoring plan and a specialized team are essential for protecting your long-term health [1][2].

Building Your Care Team

A “multi-disciplinary” team ensures that every organ affected by ADH is monitored by an expert. Your core team should include:

  • The Endocrinologist: This specialist is the lead for managing your calcium and phosphorus levels. They will oversee your vitamin D and calcium supplements [3][2]. It is ideal to work with an endocrinologist who has experience with rare metabolic bone diseases or hypoparathyroidism.
  • The Nephrologist: Because the kidneys are at high risk in ADH, a nephrologist (kidney doctor) should be involved [4][5]. They monitor for hypercalciuria (high urine calcium) and help adjust treatments to prevent kidney stones or permanent kidney damage [3][6].
  • Genetic Counselor: A counselor can help you understand your specific mutation (ADH1 vs. ADH2) and discuss the 50% chance of passing the condition to children, as well as screening strategies for other family members [7][8].

Your Surveillance Guide

Regular testing is the only way to ensure your “calcium balancing act” is working. While your doctor will customize your schedule, standard monitoring often follows these patterns:

Test Typical Frequency Why It Matters
Blood Work (Calcium, Phos, Mag, Creatinine) Every 3–6 months [9] Ensures you are in the “safe” low-normal calcium range [10].
24-Hour Urine Collection Once or twice per year [9] Measures exactly how much calcium your kidneys are losing; the “gold standard” for kidney safety [11].
Renal Ultrasound Baseline, then as needed [9] Screens for nephrocalcinosis (calcium deposits) or stones [6].

Periods of Higher Risk

Your monitoring should become more frequent during times when your body’s needs change:

  • Illness: If you are vomiting or have severe diarrhea, you may not be absorbing your calcium medications, which can lead to a rapid drop in blood levels [12].
  • Medication Changes: Any time your dose of calcium, calcitriol, or a diuretic is adjusted, you should have blood work done within 1–2 weeks to check your response [13].
  • Pregnancy: Calcium needs change significantly during pregnancy and breastfeeding. Expect to have blood and urine tests as often as every 2–4 weeks during these periods [14].

Advocacy in Action

Because ADH is rare, you may need to remind your medical team that your goals are different from other patients. If a doctor suggests “normalizing” your calcium levels into the high-normal range, use your knowledge of hypercalciuria to ask about the risks to your kidneys [5][4]. Keeping a simple log of your lab results and any symptoms can help you and your doctors spot patterns and make safer adjustments to your care [9].

-1 | Treatment Strategy

Common questions in this guide

What doctors should be on my Autosomal Dominant Hypocalcemia care team?
Your core team should include an endocrinologist to manage your calcium and vitamin D levels, and a nephrologist to monitor kidney health. A genetic counselor can also help you understand how the condition is inherited.
How often do I need blood work for Autosomal Dominant Hypocalcemia?
Typical monitoring requires blood tests every 3 to 6 months to check your calcium, phosphorus, magnesium, and creatinine levels. You will need more frequent testing if your medications change or if you become ill.
Why is a 24-hour urine test important for ADH?
A 24-hour urine test measures exactly how much calcium your kidneys are filtering out. This is the gold standard test for detecting high urine calcium and protecting your kidneys from stones or permanent damage.
What is the safest blood calcium target for someone with ADH?
The goal of ADH treatment is to keep your blood calcium in the low-normal range. Trying to push your calcium levels to a standard normal range increases the risk of dangerous calcium buildup in your kidneys.
How does pregnancy affect Autosomal Dominant Hypocalcemia management?
Your body's calcium needs change significantly during pregnancy and breastfeeding. You will likely need blood and urine tests as often as every 2 to 4 weeks to adjust your medications safely.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who is the primary 'lead' on my care team—my endocrinologist or a nephrologist who specializes in calcium disorders?
  2. 2.How often will we be checking my 24-hour urine calcium versus my serum (blood) calcium?
  3. 3.Can we establish a baseline renal ultrasound to monitor for any calcium deposits (nephrocalcinosis) over time?
  4. 4.What are my 'sick day' instructions? If I can't keep my medication down due to a stomach bug, what is the emergency protocol?
  5. 5.If I decide to become pregnant, how will my monitoring and medication schedule change?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Autosomal dominant hypocalcemia with a novel CASR mutation: a case study and literature review.

    Wu Y, Zhang C, Huang X, et al.

    The Journal of international medical research 2022; (50(7)):3000605221110489 doi:10.1177/03000605221110489.

    PMID: 35818129
  2. 2

    Activating calcium-sensing receptor gene variants in China: a case report of hypocalcaemia and literature review.

    Guo S, Li X, Shan X

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(5)):500-504 doi:10.1515/jpem-2022-0623.

    PMID: 36935580
  3. 3

    Management of autosomal dominant hypocalcemia type 1: Literature review and clinical practice recommendations.

    De Coster T, David K, Breckpot J, Decallonne B

    Journal of endocrinological investigation 2025; (48(4)):831-844 doi:10.1007/s40618-024-02496-y.

    PMID: 39607645
  4. 4

    Autosomal Dominant Hypocalcemia Type 1: A Systematic Review.

    Roszko KL, Stapleton Smith LM, Sridhar AV, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(10)):1926-1935 doi:10.1002/jbmr.4659.

    PMID: 35879818
  5. 5

    Autosomal dominant hypocalcemia type 1: Status quo of tailored management and future perspectives.

    Harada D, Namba N

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2026; doi:10.1093/jbmr/zjag034.

    PMID: 41732805
  6. 6

    Best practice recommendations for the diagnosis and management of hypoparathyroidism.

    Khan AA, Ali DS, Bilezikian JP, et al.

    Metabolism: clinical and experimental 2025; (171()):156335 doi:10.1016/j.metabol.2025.156335.

    PMID: 40581321
  7. 7

    A novel CASR mutation (p.Glu757Lys) causing autosomal dominant hypocalcaemia type 1

    Kwan B, Champion B, Boyages S, et al.

    Endocrinology, diabetes & metabolism case reports 2018; (2018()).

    PMID: 30306783
  8. 8

    A calcium-sensing receptor allelic series and underdiagnosis of genetically driven hypocalcemia.

    Chang JB, Barnhill CP, Apostolov AM, et al.

    American journal of human genetics 2025; (112(8)):1818-1832 doi:10.1016/j.ajhg.2025.06.013.

    PMID: 40664210
  9. 9

    Initial Assessment and Monitoring of Patients with Chronic Hypoparathyroidism: A Systematic Current Practice Survey.

    Van Uum S, Shrayyef M, M'Hiri I, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(12)):2630-2641 doi:10.1002/jbmr.4698.

    PMID: 36066096
  10. 10

    Association of Calcium and Phosphate Levels with Incident Chronic Kidney Disease in Patients with Hypoparathyroidism: A Retrospective Case-Control Study.

    Gosmanova EO, Ayodele O, Chen K, et al.

    International journal of endocrinology 2022; (2022()):6078881 doi:10.1155/2022/6078881.

    PMID: 36389126
  11. 11

    Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications.

    Lopes MP, Kliemann BS, Bini IB, et al.

    Archives of endocrinology and metabolism 2016; (60(6)):532-536 doi:10.1590/2359-3997000000221.

    PMID: 27901178
  12. 12

    Acute Sheehan Syndrome With Distinctive Arginine Vasopressin Secretion and Magnetic Resonance Imaging Findings.

    Minamoto Y, Sasai Y, Yamashita Y, et al.

    JCEM case reports 2025; (3(8)):luaf134 doi:10.1210/jcemcr/luaf134.

    PMID: 40657233
  13. 13

    Hypocalcemia After Thyroidectomy and Parathyroidectomy in a Pregnant Woman.

    Lebrun B, De Block C, Jacquemyn Y

    Endocrinology 2020; (161(7)) doi:10.1210/endocr/bqaa067.

    PMID: 32333773
  14. 14

    Pituitary disorders in pregnancy.

    Donald DM, Tomkins M, O'Reilly MW, Sherlock M

    Clinical medicine (London, England) 2025; (25(5)):100488 doi:10.1016/j.clinme.2025.100488.

    PMID: 40744144

This page provides educational information on long-term care and monitoring for Autosomal Dominant Hypocalcemia. Always consult your endocrinologist or nephrologist before making changes to your monitoring schedule or medication plan.

Get notified when new evidence is published on Autosomal dominant hypocalcemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.